tirzepatide vs semaglutide diabetes Efficacy of versus in achieving therapeutic targets in type 2 diabetes: a post hoc analysis of the SURPASS-2 Trial | Diabetologia tirzepatide vs semaglutide for diabetes

Adding GHK-Cu creates the GLOW stack - the most comprehensive tissue repair and skin/collagen protocol in clinical use

Nishikawa Y, Minenaka Y, Ichimura M, Tatsumi K, Nadamoto T, Urabe K

Protocol 1: Conservative foundation (beginners) Goal: Gentle immune modulation with minimal risk Components: Thymosin alpha-1: 1.6 mg subcutaneously, twice weekly BPC-157: 250 mcg subcutaneously, once daily (abdominal injection for gut support) Schedule: Monday and Thursday: Thymosin alpha-1 Daily: BPC-157 in the morning Duration: 8 weeks on, 4 weeks off Monitoring: Baseline labs before starting, repeat at week 4 and week 8

The name suggests horse gelatin, but most versions use standard bovine gelatin